Top 10 AI Research Breakthroughs Expected In 2026

A forecast of the most anticipated AI research breakthroughs in 2026, highlighting confirmed advancements and ongoing developments shaping the future of AI.

8 Best Gaming Motherboards for High-Performance PC Builds in 2026

Explore the best gaming motherboards in 2026 for high-performance PCs, including features, value, and suitability for different gamers. Updated for 2026.

What Are The Best Gaming Motherboards For 2026? Top 8 Revealed

Discover the best gaming motherboards for 2026, including top picks like ASUS ROG Strix B850-A and GIGABYTE AORUS Elite WIFI7, with detailed analysis.

10 Best Content Creator Laptops for Video, Photo, and Design Work in 2026

Discover the 10 best laptops for content creators in 2026, optimized for video editing, photo work, and design, based on hardware, performance, and value.

2026’S Top AI-Enhanced Laptops For Creative Minds

Discover the leading AI-optimized laptops for creatives in 2026, featuring powerful processors, high-res displays, and advanced AI capabilities.

Personalized Voice Training For Trans People: Pocket Voice Lab’s Approach

Pocket Voice Lab introduces an app providing real-time acoustic biofeedback for gender-affirming voice training, addressing access gaps for trans individuals.

Legendary And Warner Bros. Reveal ‘Dune’ Trailer And Behind-the-Scenes Images

Legendary Entertainment and Warner Bros. have released a trailer and exclusive images for ‘Dune,’ showcasing Abu Dhabi as Arrakis and hinting at the third film installment.

Women’s Health Radar

A new digital health tool aims to detect early signs of perimenopause in women 40-58, enabling earlier care and reducing health and work impacts.

Fable 5 Is Back. GPT-5.6 Is Next. And Anthropic Reportedly Already Has Something Stronger.

Anthropic restores Fable 5 after government blackout; OpenAI previews GPT-5.6 amid rumors of even more capable models existing privately. What’s confirmed and what’s not?

Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)

Partner Therapeutics announced the publication of clinical trial results for Zenocutuzumab in NRG1+ cholangiocarcinoma in the Journal of Clinical Oncology.